The global cell cryopreservation market size is expected to reach USD 8.86 billion by 2033, registering a CAGR of 11.40% from 2025 to 2033, according to a new report by Grand View Research, Inc. The increased use of ready-to-freeze media, combined with rising infertility rates, is driving demand for these products. Furthermore, the rising prevalence of chronic diseases, as well as the increasing importance of cell therapy for disease management, have prompted the demand for effective cryopreservation.
The increased demand for cost-effective cryopreservation medium has stemmed from increased research & development (R&D) activities to create advanced medicines. The capacity of ready-to-use media to decrease the development of ice crystals while cryopreserving live cells led to its increasing adoption among the research community. Furthermore, the rising popularity of cell-based drugs has resulted in massive investments from manufacturers to develop sophisticated biopharmaceuticals for serious medical conditions, which will propel the demand for cryopreservation and further boost the market growth.
The rapid R&D for the COVID-19 vaccine, as well as its continued commercial manufacturing activities, have also significantly impacted and stimulated biologics-based research activities, resulting in increased market growth. Furthermore, the growing market demand, increased competition among competitors, and diverse applications by end-users have all contributed to developments in cryopreservation freezing media formulations, which are now even accessible on a custom basis. For example, Merck KGaA's Sigma Aldrich brand provides frozen media solutions for stem cell applications while ensuring optimal recovery and cell survival, thus, propelling the cryopreservation market growth.
The versatility, ready-to-use, and inexpensive cost of these media over traditional freezing processes have resulted in widespread adoption among end-users. Traditional freezing processes necessitate the use of liquid nitrogen, which has significant safety concerns. Other disadvantages of nitrogen use include the potential of cross-contamination, high operating costs, and the risk of asphyxiation due to the displacement of atmospheric oxygen. As a result, the use of ready-to-use freezing media has grown in recent years which further boosts the cryopreservation market.
Additionally, developments in freezing media formulation and cryopreservation techniques, as well as leveraging cryopreservation freezing media applications in fields such as tissue engineering, cellular treatment, and stem cell research, have driven the market at a substantial rate. Favorable government regulations for regenerative medicine & cell-based research are expected to further boost the global market.
Request a free sample copy or view report summary: Cell Cryopreservation Market Report
Based on product, the consumables segment held 41.87% of the global revenue share in 2024. The freezing media segment is expected to witness significant growth during the forecast period.
The stem cell application segment held the largest market share of 30.97% in 2024.Reproductive cells are expected to witness the fastest CAGR during the forecast period.
Biopharmaceutical and pharmaceutical companies accounted for the largest share in the global cell cryopreservation market in 2024, holding 36.63% of the market.Biobanks are expected to experience the fastest CAGR due to their importance as research and clinical repositories for tissues and cells.
North America held the largest market share of 40.46% in 2024. The U.S. cell cryopreservation industry is driven by advances in regenerative medicine, cell and gene therapies, and fertility preservation.
Asia Pacific is projected to witness the fastest growth in the cell cryopreservation market, driven by rising adoption in countries such as China and Japan.
Grand View Research has segmented global cell cryopreservation market on the basis of product, application, end-use, and region:
Cell Cryopreservation Product Outlook (Revenue, USD Million, 2021 - 2033)
Cell Freezing Media
Ethylene Glycol
Dimethyl Sulfoxide
Glycerol
Others
Equipment
Freezers
Incubators
Liquid Nitrogen Supply Tanks
Consumables
Cryogenic vials
Cryogenic tubes
Cooler boxes/containers
Others
Cell Cryopreservation Application Outlook (Revenue, USD Million, 2021 - 2033)
Stem Cells
Reproductive Cells
Bioproduction Cell Lines
Primary Cells
Others
Cell Cryopreservation End-use Channel Outlook (Revenue, USD Million, 2021 - 2033)
Biopharmaceutical & Pharmaceutical Companies
Academic and Research Institutes
Biobanks
IVF Clinics
Others
Cell Cryopreservation Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Cell Cryopreservation Market
Thermo Fisher Scientific Inc.
Merck KGaA
Sartorius AG
BioLife Solutions Inc.
PromoCell GmbH
Lonza
HiMedia Laboratories
Creative Biolabs
Corning Incorporated
"The quality of research they have done for us has been excellent..."